Anti-ischemic effects of angiotensin-converting enzyme inhibition in hypertension

Abhiram Prasad, Rita Mincemoyer, Arshed A. Quyyumi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

OBJECTIVES: We investigated whether augmentation df bradykinin (BK) bioavailability with angiotensin-converting enzyme (ACE) inhibition is associated with reduced exercise-induced myocardial ischemia in hypertension. BACKGROUND: Bradykinin responses are depressed in hypertension, and endothelial dysfunction contributes to myocardial ischemia by promoting abnormal coronary vasomotion during stress. METHODS: Fourteen hypertensive (HT) and 17 normotensive (NT), mildly symptomatic patients with coronary artery disease (CAD) and ST-segment depression during exercise were studied before and after seven days of oral enalapril (EN), which was titrated from 2.5 to 20 mg daily. Patients underwent two treadmill exercise tests and determination of forearm vasodilator response to BK. RESULTS: Despite receiving a lower dose of EN (7.8 vs. 14.8 mg, p<0.001), NT patients had a significant reduction in blood pressure compared to HT patients. Compared to pre-EN, the ischemic threshold, defined as the rate-pressure product at the onset of 1-mm ST depression (p=0.045), the duration of exercise to 1-mm ST depression (180±54 s, p=0.007) and the maximum exercise duration (94±18 s, p<0.001) were greater after EN in HT patients, but not in NT subjects (all p≥0.3). Patients with a greater drop in blood pressure experienced no improvement in exercise-induced ischemia. Forearm blood flow responses to BK were improved with EN in all patients to a similar extent. Moreover, no correlation was observed between the basal response to BK or the magnitude of its improvement with EN and with either the dose of EN or the improvement in exercise ischemic threshold. CONCLUSIONS: Exercise-induced myocardial ischemia is ameliorated in HT patients with CAD by ACE inhibition.

Original languageEnglish (US)
Pages (from-to)1116-1122
Number of pages7
JournalJournal of the American College of Cardiology
Volume38
Issue number4
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Peptidyl-Dipeptidase A
Enalapril
Hypertension
Bradykinin
Exercise
Myocardial Ischemia
Exercise Test
Forearm
Coronary Artery Disease
Blood Pressure
Vasodilator Agents
Biological Availability
Ischemia
Pressure

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Anti-ischemic effects of angiotensin-converting enzyme inhibition in hypertension. / Prasad, Abhiram; Mincemoyer, Rita; Quyyumi, Arshed A.

In: Journal of the American College of Cardiology, Vol. 38, No. 4, 2001, p. 1116-1122.

Research output: Contribution to journalArticle

Prasad, Abhiram ; Mincemoyer, Rita ; Quyyumi, Arshed A. / Anti-ischemic effects of angiotensin-converting enzyme inhibition in hypertension. In: Journal of the American College of Cardiology. 2001 ; Vol. 38, No. 4. pp. 1116-1122.
@article{a20ee87e1d164e4f989c6fb321f6a221,
title = "Anti-ischemic effects of angiotensin-converting enzyme inhibition in hypertension",
abstract = "OBJECTIVES: We investigated whether augmentation df bradykinin (BK) bioavailability with angiotensin-converting enzyme (ACE) inhibition is associated with reduced exercise-induced myocardial ischemia in hypertension. BACKGROUND: Bradykinin responses are depressed in hypertension, and endothelial dysfunction contributes to myocardial ischemia by promoting abnormal coronary vasomotion during stress. METHODS: Fourteen hypertensive (HT) and 17 normotensive (NT), mildly symptomatic patients with coronary artery disease (CAD) and ST-segment depression during exercise were studied before and after seven days of oral enalapril (EN), which was titrated from 2.5 to 20 mg daily. Patients underwent two treadmill exercise tests and determination of forearm vasodilator response to BK. RESULTS: Despite receiving a lower dose of EN (7.8 vs. 14.8 mg, p<0.001), NT patients had a significant reduction in blood pressure compared to HT patients. Compared to pre-EN, the ischemic threshold, defined as the rate-pressure product at the onset of 1-mm ST depression (p=0.045), the duration of exercise to 1-mm ST depression (180±54 s, p=0.007) and the maximum exercise duration (94±18 s, p<0.001) were greater after EN in HT patients, but not in NT subjects (all p≥0.3). Patients with a greater drop in blood pressure experienced no improvement in exercise-induced ischemia. Forearm blood flow responses to BK were improved with EN in all patients to a similar extent. Moreover, no correlation was observed between the basal response to BK or the magnitude of its improvement with EN and with either the dose of EN or the improvement in exercise ischemic threshold. CONCLUSIONS: Exercise-induced myocardial ischemia is ameliorated in HT patients with CAD by ACE inhibition.",
author = "Abhiram Prasad and Rita Mincemoyer and Quyyumi, {Arshed A.}",
year = "2001",
doi = "10.1016/S0735-1097(01)01506-6",
language = "English (US)",
volume = "38",
pages = "1116--1122",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Anti-ischemic effects of angiotensin-converting enzyme inhibition in hypertension

AU - Prasad, Abhiram

AU - Mincemoyer, Rita

AU - Quyyumi, Arshed A.

PY - 2001

Y1 - 2001

N2 - OBJECTIVES: We investigated whether augmentation df bradykinin (BK) bioavailability with angiotensin-converting enzyme (ACE) inhibition is associated with reduced exercise-induced myocardial ischemia in hypertension. BACKGROUND: Bradykinin responses are depressed in hypertension, and endothelial dysfunction contributes to myocardial ischemia by promoting abnormal coronary vasomotion during stress. METHODS: Fourteen hypertensive (HT) and 17 normotensive (NT), mildly symptomatic patients with coronary artery disease (CAD) and ST-segment depression during exercise were studied before and after seven days of oral enalapril (EN), which was titrated from 2.5 to 20 mg daily. Patients underwent two treadmill exercise tests and determination of forearm vasodilator response to BK. RESULTS: Despite receiving a lower dose of EN (7.8 vs. 14.8 mg, p<0.001), NT patients had a significant reduction in blood pressure compared to HT patients. Compared to pre-EN, the ischemic threshold, defined as the rate-pressure product at the onset of 1-mm ST depression (p=0.045), the duration of exercise to 1-mm ST depression (180±54 s, p=0.007) and the maximum exercise duration (94±18 s, p<0.001) were greater after EN in HT patients, but not in NT subjects (all p≥0.3). Patients with a greater drop in blood pressure experienced no improvement in exercise-induced ischemia. Forearm blood flow responses to BK were improved with EN in all patients to a similar extent. Moreover, no correlation was observed between the basal response to BK or the magnitude of its improvement with EN and with either the dose of EN or the improvement in exercise ischemic threshold. CONCLUSIONS: Exercise-induced myocardial ischemia is ameliorated in HT patients with CAD by ACE inhibition.

AB - OBJECTIVES: We investigated whether augmentation df bradykinin (BK) bioavailability with angiotensin-converting enzyme (ACE) inhibition is associated with reduced exercise-induced myocardial ischemia in hypertension. BACKGROUND: Bradykinin responses are depressed in hypertension, and endothelial dysfunction contributes to myocardial ischemia by promoting abnormal coronary vasomotion during stress. METHODS: Fourteen hypertensive (HT) and 17 normotensive (NT), mildly symptomatic patients with coronary artery disease (CAD) and ST-segment depression during exercise were studied before and after seven days of oral enalapril (EN), which was titrated from 2.5 to 20 mg daily. Patients underwent two treadmill exercise tests and determination of forearm vasodilator response to BK. RESULTS: Despite receiving a lower dose of EN (7.8 vs. 14.8 mg, p<0.001), NT patients had a significant reduction in blood pressure compared to HT patients. Compared to pre-EN, the ischemic threshold, defined as the rate-pressure product at the onset of 1-mm ST depression (p=0.045), the duration of exercise to 1-mm ST depression (180±54 s, p=0.007) and the maximum exercise duration (94±18 s, p<0.001) were greater after EN in HT patients, but not in NT subjects (all p≥0.3). Patients with a greater drop in blood pressure experienced no improvement in exercise-induced ischemia. Forearm blood flow responses to BK were improved with EN in all patients to a similar extent. Moreover, no correlation was observed between the basal response to BK or the magnitude of its improvement with EN and with either the dose of EN or the improvement in exercise ischemic threshold. CONCLUSIONS: Exercise-induced myocardial ischemia is ameliorated in HT patients with CAD by ACE inhibition.

UR - http://www.scopus.com/inward/record.url?scp=0034811479&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034811479&partnerID=8YFLogxK

U2 - 10.1016/S0735-1097(01)01506-6

DO - 10.1016/S0735-1097(01)01506-6

M3 - Article

C2 - 11583891

AN - SCOPUS:0034811479

VL - 38

SP - 1116

EP - 1122

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 4

ER -